Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

Diabetes Care

Volumn 27, Issue 12, 2004, Pages 2800-2805

  Pladevall, Manel ^a   Williams, L Keoki ^a   Potts, Lisa Ann ^b   Divine, George ^a   Xi, Hugo ^a   Lafata, Jennifer Elston ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; STATISTICAL SIGNIFICANCE;

ADULT; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSURANCE CLAIM REVIEW; MALE; MICHIGAN; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 9444241529     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.12.2800     Document Type: Article

References (35)

1. Dunbar-Jacob J, Mortimer-Stephens MK: Treatment adherence in chronic disease. J Clin Epidemiol 54:S57-S60, 2001
2. Haynes RB, McDonald H, Garg AX, Montague P: Interventions for helping patients to follow prescriptions for medications (Review). Cochrane Database Syst Rev CD000011, 2002
3. Sabaté E: Adherence to long-term therapies: evidence for action. Geneva, World Health Org. [article online]. Accessed 5 March 2004. Available from http://www.who.int/chronic_conditions/adherencereport/en/
4. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B: Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 36:1138-1161, 1998
5. DiMatteo MRP: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42:200-209, 2004
6. Cramer JA: A systematic review of adherence with medications for diabetes. Diabetes Care 27:1218-1224, 2004
7. Hughes DA, Bagust A, Haycox A, Walley T: The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 10:601-615, 2001
8. Walker EA, Usher JA: Understanding and enhancing adherence in adults with diabetes. Curr Diab Rep 3:141-148, 2003
9. Kidd KE, Altman DG: Adherence in social context. Control Clin Trials 21:184-187, 2000
10. Ellis S, Shumaker S, Sieber W, Rand C: Adherence to pharmacological interventions: current trends and future directions: the Pharmacological Intervention Working Group. Control Clin Trials 21 (Suppl. 5):S218-S225, 2000
11. Turner BJ, Hecht FM: Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 134:1004-1006, 2001
12. Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA: Measuring adherence to behavioral and medical interventions. Control Clin Trials 21:188-194, 2000
13. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37:846-857, 1999
14. Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50:105-116, 1997
15. Gray A, Clarke P, Farmer A, Holman R: Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63) (Letter). BMJ 325:860, 2002
16. CDC Diabetes Cost-effectiveness Group: Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287:2542-2551, 2002
17. Egede LE, Zheng D: Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. Arch Intern Med 162:427-433, 2002
18. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342, 2004
19. Kolodner K, Lipton R, Elston Lafata J, Leotta C, Liberman J, Chee E, Moon C: Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity. J Clin Epidemiol 57:959-969, 2004
20. 1c. Diabetes Care 23:919-927, 2000
21. Nichols GA, Hillier TA, Javor K, Brown JB: Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care 23:273-277, 2000
22. Schectman JM, Nadkarni MM, Voss JD: The association between diabetes, metabolic control, and drug adherence in an indigent population. Diabetes Care 25:1015-1021, 2002
23. Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA: How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care 26:738-743, 2003
24. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, Kaplan S, Rogers WH: Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 12:93-102, 1993
25. Farley J, Hines S, Musk A, Ferrus S, Tepper V: Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr 33:211-218, 2003
26. Burnier M, Brunner HR: Impact on clinical outcomes. In Compliance in Healthcare and Research. Burke LE, Ockene IS, Eds. Armonk, New York, Futura, 2001, p. 299-316
27. Applegate WB: Elderly patients' adherence to statin therapy. JAMA 288:495-497, 2002
28. Rand CS, Sevick MA: Ethics in adherence promotion and monitoring. Control Clin Trials 21 (Suppl. 5):S241-S247, 2000
29. Glasgow RE, Anderson RM: In diabetes care, moving from compliance to adherence is not enough: something entirely different is needed. Diabetes Care 22:2090-2092, 1999
30. Schectman JM, Schorling JB, Nadkarni MM, Voss JD: Can prescription refill feedback to physicians improve patient adherence? Am J Med Sci 327:19-24, 2004
31. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA: Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 42:409-422, 2004
32. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients with chronic illness. JAMA 288:1775-1779, 2002
33. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients with chronic illness: the chronic care model. Part 2. JAMA 288:1909-1914, 2002
34. Schiff GD, Rucker TD: Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA 279:1024-1029, 1998
35. Richardson WC, Berwick DM, Bisgard JC: The Institute of Medicine report on medical errors (Letter). N Engl J Med 343:663-664, 2000